Rare diseases
Investigational molecules
Locations
239 conditions with trials, the busiest first
755 trials across Europe, recruiting first
Comparing the efficacy and safety of KAI-9531 and semaglutide in people living with obesity who do not have diabetes
BulgariaA study to evaluate the efficacy and safety of zenagamtide in people with obesity
BelgiumA study comparing the effectiveness of vorolanib and aflibercept in patients with diabetic macular edema
GermanyA study to evaluate the effects of obicetrapib and ezetimibe on cholesterol levels in adults with type 2 diabetes or metabolic syndrome
CzechiaA study comparing the effectiveness of vorolanib and aflibercept in patients with diabetic macular edema
CzechiaOrlistat (EMP22) and Drug Combination (acarbose + orlistat) in Healthy Volunteers with Obesity
SwedenSafety, Tolerability and Pharmacokinetics of MK-7480 and Diltiazem Hydrochloride in Healthy Adult Male Participants for Non‑alcoholic Steatohepatitis
BelgiumBioequivalence Study of Dapagliflozin 10 mg Tablets in Healthy Adult Volunteers with Diabetes
RomaniaSafety and Tolerability of REGN7999 in Healthy Adult Participants
BelgiumSingle‑dose Bioavailability of Gliclazide Modified‑Release Tablets in Healthy Volunteers (Type 2 Diabetes)
PortugalBioequivalence Study of Linagliptin 5 mg Film‑Coated Tablets in Healthy Volunteers for Diabetes Treatment
Spain
The NetherlandsThe therapies tested most often in Metabolism and nutrition disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
